Skip to main content
See every side of every news story
Published loading...Updated

Local Health Officials Call HHS Decision to Pull Vaccine Funding ‘Unethical’; Say It Will Affect Research, Employment

UNITED STATES, AUG 6 – HHS Secretary Robert F. Kennedy Jr. cited ineffectiveness against respiratory diseases to redirect $500 million from mRNA vaccines to whole-virus and novel vaccine platforms.

  • On Tuesday, the Department of Health and Human Services announced it would terminate $500 million in mRNA vaccine contracts, halting related research.
  • Amid a comprehensive BARDA review, Kennedy, HHS Secretary, said vaccines “fail to protect effectively against upper respiratory infections like COVID and flu”, prompting a shift to broader platforms.
  • Covering 22 contracts, the wind-down includes termination of an award to Moderna and UTMB, and ending contracts with Emory University and Tiba Biotech, plus de-scoping at Luminary Labs, ModeX, and Seqirus.
  • Local centers, including the Jacksonville Center for Clinical Research, are impacted, with Dr. Michael Koren calling the surprise move unethical and warning of employment risks.
  • Public health experts warn this rollback could hinder future vaccine readiness amid rising COVID and RSV season, and John Fleetwood argues it masks a shift toward bird flu preparedness.
Insights by Ground AI
Podcasts & Opinions

102 Articles

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 55% of the sources are Center
55% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

der Standard AT broke the news in Vienna, Austria on Wednesday, August 6, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal